Hillsdale Investment Management Inc.

Position in GH — Guardant Health, Inc.

CIK 1368465 Toronto, A6

Position in GH

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$11,489,350

-$1,010,543 QoQ

Shares Held

124,384

+1.6% QoQ

Ownership

0.094%

of shares outstanding

% of Portfolio

0.32%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

6 quarters on record

Voting authority Sole 97.58489837921276.ToString("F0")% Shared 0.ToString("F0")% None 2.4151016207872393.ToString("F0")%

Healthcare · as of Mar 31, 2026

Hillsdale Investment Management Inc. holds $21,291,906 across 4 Diagnostics & Research names. GH ranks #1 (54.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GH	Guardant Health, Inc. This page	124,384	$11,489,350
2	ADPT	Adaptive Biotechnologies Corp	625,217	$8,678,011
3	IQV	Iqvia Holdings Inc.	4,980	$849,289
4	TMO	Thermo Fisher Scientific Inc.	560	$275,256

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$11,489,350	124,384	+1.6%	Shares	Sole	2026-05-04
2025-12-31	$12,499,893	122,380	-21.5%	Shares	Sole	2026-02-10
2025-09-30	$9,740,632	155,900	+14.5%	Shares	Sole	2025-11-10
2025-06-30	$7,082,644	136,100	-0.2%	Shares	Sole	2025-08-12
2023-12-31	$3,689,079	136,380	-6.7%	Shares	Sole	2024-02-09
2023-09-30	$4,330,404	146,100	—	Shares	Sole	2023-11-09
No filing history on record for this holder in this stock.